| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |